GB0917072D0 - Peptide analogues of glucagon for diabetes therapy - Google Patents
Peptide analogues of glucagon for diabetes therapyInfo
- Publication number
- GB0917072D0 GB0917072D0 GB0917072A GB0917072A GB0917072D0 GB 0917072 D0 GB0917072 D0 GB 0917072D0 GB 0917072 A GB0917072 A GB 0917072A GB 0917072 A GB0917072 A GB 0917072A GB 0917072 D0 GB0917072 D0 GB 0917072D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- glucagon
- peptide analogues
- diabetes therapy
- diabetes
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical class C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0917072A GB0917072D0 (en) | 2009-09-29 | 2009-09-29 | Peptide analogues of glucagon for diabetes therapy |
| PCT/EP2010/005943 WO2011038900A2 (en) | 2009-09-29 | 2010-09-29 | Peptide analogues of glucagon for diabetes therapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0917072A GB0917072D0 (en) | 2009-09-29 | 2009-09-29 | Peptide analogues of glucagon for diabetes therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0917072D0 true GB0917072D0 (en) | 2009-11-11 |
Family
ID=41350545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0917072A Ceased GB0917072D0 (en) | 2009-09-29 | 2009-09-29 | Peptide analogues of glucagon for diabetes therapy |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0917072D0 (en) |
| WO (1) | WO2011038900A2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8541368B2 (en) * | 2011-09-23 | 2013-09-24 | Novo Nordisk A/S | Glucagon analogues |
| GB201214493D0 (en) * | 2012-08-14 | 2012-09-26 | Univ Ulster | Therapies |
| AU2014255608B2 (en) | 2013-04-18 | 2018-01-25 | Novo Nordisk A/S | Stable, protracted GLP-1/glucagon receptor co-agonists for medical use |
| EP3151852A1 (en) | 2014-06-04 | 2017-04-12 | Novo Nordisk A/S | Glp-1/glucagon receptor co-agonists for medical use |
| US10046058B2 (en) | 2014-12-02 | 2018-08-14 | Rezolute, Inc. | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates |
| PE20230304A1 (en) | 2014-12-30 | 2023-02-13 | Hanmi Pharm Ind Co Ltd | GLUCAGON DERIVATIVES AS HYPOGLYCEMIC AND ANTI-OBESITY AGENTS |
| JOP20200119A1 (en) * | 2015-01-09 | 2017-06-16 | Lilly Co Eli | Gip and glp-1 co-agonist compounds |
| EP3302450A4 (en) | 2015-06-04 | 2019-01-16 | Antriabio, Inc. | METHODS OF AMINE PEGYLATION FOR THE PREPARATION OF SPECIFIC PROTEIN CONJUGATES OF A SITE |
| CN108025041A (en) | 2015-06-30 | 2018-05-11 | 韩美药品株式会社 | Hyperglycemic factor derivative and the composition for including its long-acting conjugate |
| HK1258177A1 (en) | 2015-12-31 | 2019-11-08 | Hanmi Pharm. Co., Ltd. | Persistent conjugate of triple activator activating glucagon, glp-1 and gip receptor |
| SG11201811697SA (en) | 2016-06-29 | 2019-01-30 | Hanmi Pharmaceutical Co Ltd | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5480867A (en) * | 1993-12-29 | 1996-01-02 | The Rockefeller University | Glucagon analogs with serine replacements |
| US6677136B2 (en) * | 2000-05-03 | 2004-01-13 | Amgen Inc. | Glucagon antagonists |
| AR036711A1 (en) | 2001-10-05 | 2004-09-29 | Bayer Corp | PEPTIDES THAT ACT AS GLON-RECEPTOR AGONISTS AND AS GLUCAGON RECEPTOR ANTAGONISTS AND THEIR PHARMACOLOGICAL USE METHODS |
| AU2003260306A1 (en) | 2002-07-17 | 2004-02-02 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | Bicyclic oligopeptides |
| US20050124550A1 (en) * | 2003-06-18 | 2005-06-09 | Peri Krishna G. | Compounds that modulate the glucagon response and uses thereof |
| CA2665033C (en) | 2006-10-03 | 2013-10-01 | Cadila Healthcare Limited | Antidiabetic compounds |
| WO2009058734A1 (en) * | 2007-10-30 | 2009-05-07 | Indiana University Research And Technology Corporation | Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| WO2009058662A2 (en) * | 2007-10-30 | 2009-05-07 | Indiana University Research And Technology Corporation | Glucagon antagonists |
-
2009
- 2009-09-29 GB GB0917072A patent/GB0917072D0/en not_active Ceased
-
2010
- 2010-09-29 WO PCT/EP2010/005943 patent/WO2011038900A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011038900A2 (en) | 2011-04-07 |
| WO2011038900A3 (en) | 2011-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0917072D0 (en) | Peptide analogues of glucagon for diabetes therapy | |
| AP3286A (en) | Glucagon analogues | |
| EP2328922A4 (en) | Analogues of glucose-dependent insulinotropic polypeptide | |
| ZA201206838B (en) | Novel glucagon analogues | |
| AP2013006671A0 (en) | Glucagon analogues | |
| IL252058A0 (en) | Peptide analogs of alpha-melanocyte stimulating hormone | |
| AP3329A (en) | Acylated glucagon analogues | |
| PT2320923E (en) | Truncated analogues of glucose-dependent insulinotropic polypeptide | |
| ZA201104592B (en) | Glucagon analogues | |
| IL213478A0 (en) | Glucagon analogues | |
| IL213480A0 (en) | Glucagon analogues | |
| IL213477A0 (en) | Glucagon analogues | |
| IL231199A0 (en) | Novel glucagon analogues | |
| EP2323678A4 (en) | Glucose-dependent insulinotropic polypeptide analogues | |
| IL227869A0 (en) | Novel glucagon analogues | |
| PL2496596T3 (en) | Therapeutic peptides | |
| EP2576612A4 (en) | Insulin analogues | |
| ZA201204308B (en) | Insulin analogues with chlorinated amino acids | |
| IL250733A0 (en) | Pharmaceutical preparation comprising recombinant hcg | |
| IL215245A0 (en) | Use of nkp46 for preventing diabetes | |
| ZA201003844B (en) | Delivery of functional compounds | |
| ZA201007911B (en) | Processes for refolding of insulin | |
| GB2468757B (en) | Method of screening a drug such as insulin secretagogue | |
| GB0919603D0 (en) | Use of thymosin beta-4 for treatment of type II diabetes | |
| HK1177622A (en) | Glucagon analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |